Skip to main content

Respiratory Diseases in the Newborn

  • Chapter
  • First Online:
Pediatric Respiratory Diseases

Abstract

Respiratory diseases are frequently caused by immature respiratory and cardiovascular systems in the premature newborn and by adaptation mechanisms related to asphyxia and congenital malformations in the full-term newborn. Perinatal infections affect both premature and full-term newborns. Respiratory diseases can be classified as those caused by (a) perinatal asphyxia, (b) related to immaturity and lung liquid reabsorption, (c) related to lung circulation, (d) caused by infections in the newborn, and (e) caused by congenital alterations of the airway and lungs. The clinical picture is usually referred to as respiratory distress syndrome characterized by the presence of tachypnea, retraction, grunting, cyanosis, and apnea, whether of a respiratory or nonrespiratory source. A detailed perinatal anamnesis based on risk factors, an exhaustive physical examination, and complementary laboratory testing are essential for determining a precise diagnosis. Adequate management of each condition depends on the understanding of the underlying physiopathological mechanisms. Respiratory diseases increase mortality and morbidity rates in the newborn. The change from intrauterine breathing through the placenta to the external pulmonary breathing grants a unique feature to these problems, which are, to a great extent, caused by the alteration of the cardiopulmonary adaptation. In premature newborns, immature respiratory and cardiovascular systems are the most important cause of respiratory diseases. For the term newborn, adaptation mechanisms are mainly altered by asphyxia and congenital malformations. Perinatal infections affect both term and preterm newborns and are a frequent cause of respiratory problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Sources

  • Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.

    PubMed  Google Scholar 

  • Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics. 2014;133:171–4.

    Article  Google Scholar 

  • Fehlmann E, Tapia JL, Fernández R, Bancalari A, Fabres J, D’Apremont I, García-Zattera MJ, Grandi C, Ceriani Cernadas JM, Grupo Colaborativo Neocosur. Impacto del síndrome de dificultad respiratoria en recién naci-dos de muy bajo peso de nacimiento: estudio multicéntrico sudamericano. Arch Argent Pediatr. 2010;108(5):393–400.

    PubMed  Google Scholar 

  • Finer NN, Carlo WA, Walsh MC, et al. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;362(21):1970–9.

    Article  CAS  Google Scholar 

  • González A, Sosenko Y, Chandar J y cols. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000g or less. J Pediatr. 1996;128:470.

    Article  Google Scholar 

  • González A, Fabres J, D’Apremont I, Urcelay G, Avaca M, Gandolfi C, Kattan J. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension. J Perinatol. 2010;30(6):420–4.

    Article  Google Scholar 

  • Grupo Colaborativo Neocosur. Very low birth weight infants outcome in 11 South American NICU’s. J Perinatol. 2002;22:2–7.

    Article  Google Scholar 

  • Hahn S, Choi HJ, Soll R, Dargaville PA. Lung lavage for meconium aspiration syndrome in newborn infants. Cochrane Database Syst Rev. 2013;4:CD003486.

    Google Scholar 

  • Halliday HL, Sweet D. Endotracheal intubation at birth for preventing morbidity and mortality in vigorous, meconium-stained infants born at term. Cochrane Library. 2003;1:CD000500.

    Google Scholar 

  • Henderson-Smart DJ, Steer PA. Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev. 2010;1:CD000273.

    Google Scholar 

  • Ministerio de Salud Chile. Guía Clínica AUGE, Síndrome de dificultad respiratoria del recién nacido. Garantías Explícitas en Salud. Noviembre 2011. www.supersalud.gob.cl.

  • Murphy KE, Hannah ME, Willan AR, et al. MACS Collaborative Group. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet. 2008;372:2143–51.

    Article  CAS  Google Scholar 

  • NIH Consensus Conference. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995;273(5):413–18.

    Google Scholar 

  • Porta NF, Steinhorn RH. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol. 2012;39(1):149–64.

    Article  Google Scholar 

  • Rojas-Reyes MX, Morley CJ, Soll R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3:CD000510.

    Google Scholar 

  • Tapia JL, Urzúa S, Bancalari A, Meritano J, Torres G, Fabres J, Toro CA, Rivera F, Céspedes E, Burgos JF, Mariani G, Roldán L, Silvera F, González A, Domínguez A. Randomized trial of early bubble continuous positive airway pressure (CPAP) for very low birth weight infants. J Pediatr. 2012;165:75–80.

    Article  Google Scholar 

  • Vento M. Oxygen supplementation in the neonatal period: changing the paradigm. Neonatology. 2014;105:323–31.

    Article  CAS  Google Scholar 

  • Weisman LE, Hansen TN. Contemporary diagnosis and management of: neonatal respiratory diseases. 3rd ed. Newton: Handbooks in Health Care; 2003.

    Google Scholar 

  • Weisz DE, McNamara PJ. Patent ductus arteriosus ligation and adverse outcomes: causality or bias? J Clin Neonatol. 2014;3(2):67–75.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Javier Kattan Said .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tapia Illanes, J.L., Toso Milos, P., Kattan Said, J. (2020). Respiratory Diseases in the Newborn. In: Bertrand, P., Sánchez, I. (eds) Pediatric Respiratory Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-26961-6_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26961-6_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26960-9

  • Online ISBN: 978-3-030-26961-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics